DD

Drug Development Consultants at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Drug Development Consultants brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program sits in the USP emerging standards track. It covers proposed revisions to the USP guidance on evaluating the biological safety of new excipients.

OrganizationAAPS 2026 PharmSci 360 Attendance
DD
Drug Development Consultants
Talk
Tue Oct 27
3:10pm–3:50pm
Part of USP Emerging Standards
USP’s Pathway to Address Stakeholder Needs on Novel Excipients - Revisions to <1074> Excipient Biological Safety Evaluation Guidelines
USP Spotlight Stage, Exhibit Hall
USP Emerging Standards
Talk
Tue Oct 27
4:15pm–4:45pm
Part of USP Emerging Standards
Panel Discussion and Q&A
USP Spotlight Stage, Exhibit Hall
USP Emerging Standards · with USP, Creekmore Pharma Consulting, Ascendia Pharmaceutical Solutions +1 more

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Drug Development Consultants

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction